ID: ALA4580852

Max Phase: Preclinical

Molecular Formula: C61H75ClN8O16S5

Molecular Weight: 1372.10

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCOCCOCCNC(=O)CCCCCC1(C)C(/C=C/C=C/C=C3/N(CCCS(=O)(=O)O)c4ccc(S(=O)(=O)O)cc4C3(C)C)=[N+](CCCS(=O)(=O)[O-])c3ccc(S(=O)(=O)O)cc31)c1nnc(C)n1-2

Standard InChI:  InChI=1S/C61H75ClN8O16S5/c1-40-41(2)87-59-56(40)57(43-18-20-44(62)21-19-43)65-49(58-67-66-42(3)70(58)59)39-55(72)64-28-32-86-34-33-85-31-27-63-54(71)17-11-8-12-26-61(6)48-38-46(91(82,83)84)23-25-51(48)69(30-14-36-89(76,77)78)53(61)16-10-7-9-15-52-60(4,5)47-37-45(90(79,80)81)22-24-50(47)68(52)29-13-35-88(73,74)75/h7,9-10,15-16,18-25,37-38,49H,8,11-14,17,26-36,39H2,1-6H3,(H5-,63,64,71,72,73,74,75,76,77,78,79,80,81,82,83,84)/t49-,61?/m0/s1

Standard InChI Key:  GMNBZAPLLBMPMH-YUYUPMSPSA-N

Associated Targets(Human)

Bromodomain-containing protein 2 1296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bromodomain-containing protein 3 1086 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bromodomain-containing protein 4 13122 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1372.10Molecular Weight (Monoisotopic): 1370.3593AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Richardson PL, Marin VL, Koeniger SL, Baranczak A, Wilsbacher JL, Kovar PJ, Bacon-Trusk PE, Cheng M, Hopkins TA, Haman ST, Vasudevan A..  (2019)  Controlling cellular distribution of drugs with permeability modifying moieties.,  10  (6): [PMID:31303996] [10.1039/C8MD00412A]

Source